Found 545563 clinical trials
Sort by:
Chitosan and i-PRF in Palatal Wound Healing
Not Applicable
Not yet recruiting
- Conditions
- Free Gingival GraftWound Healingi-PRFChitosan
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Biruni University
- Target Recruit Count
- 75
- Registration Number
- NCT07072546
Impact Of Intralesional Tuberculin Ppd Injection On Anogenital
Not Applicable
Completed
- Conditions
- Human Papilloma VirusInfections
- Interventions
- Drug: protein purified derivative
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Universitas Padjadjaran
- Target Recruit Count
- 24
- Registration Number
- NCT07072065
- Locations
- 🇮🇩
Venereology Clinic, Dr. Hasan Sadikin Hospital, Bandung, Jawa Barat, Indonesia
Skin Condition of Term Newborns During Diaper Care for Meconium Removal
Not Applicable
Completed
- Conditions
- Infant ALLSkin
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Acibadem University
- Target Recruit Count
- 96
- Registration Number
- NCT07072130
- Locations
- 🇹🇷
Acıbadem University, Istanbul, Ataşehir, Turkey
EEG During Gastroscopy and/or Colonoscopy
Not Applicable
Not yet recruiting
- Conditions
- Endoscopy of Stomach (Procedure)Colonoscopy (Procedure)Continuous Processed Electroencephalogram (Procedure)
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Erasme University Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT07073274
- Locations
- 🇧🇪
H.U.B _ Hôpital Erasme, Brussels, Belgium
During Inhaler Application, Children Were Given Stress Ball and Storybook Reading Interventions
Not Applicable
Not yet recruiting
- Conditions
- Inhalation Therapy
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Ataturk University
- Target Recruit Count
- 99
- Registration Number
- NCT07073625
- Locations
- 🇹🇷
Erzurum City Hospital, Erzurum, Center, Turkey
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation
Not Applicable
Not yet recruiting
- Conditions
- Impaired Glucose RegulationImpaired Glucose Tolerance (Prediabetes)Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)Cognitive DysfunctionNeurovascular Coupling Mechanism and Cognitive Function
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Leeds Beckett University
- Target Recruit Count
- 70
- Registration Number
- NCT07073781
- Locations
- 🇬🇧
Leeds Beckett University, Leeds, Greater Manchester, United Kingdom
Evaluation of Artificial Intelligence System in Diagnosis of Colorectal Tubular Adenoma Lesions
Recruiting
- Conditions
- Colorectal AdenomaArtificial Intelligence (AI) in Diagnosis
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Renmin Hospital of Wuhan University
- Target Recruit Count
- 4200
- Registration Number
- NCT07073430
- Locations
- 🇨🇳
Renmin Hospital of Wuhan University, Wuhan, Hubei, China
Local Therapy After FLAURA2 in EGFR-mutant NSCLC (PNU-0002)
Not Applicable
Recruiting
- Conditions
- Non-Small Cell Lung CancerEpidermal Growth Factor Receptor
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Pusan National University Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT07073365
- Locations
- 🇰🇷
Pusan National University Hospital, Busan, Korea, Republic of
A Single-Center Clinical Study on the Efficacy and Safety of Xinwell Ureteroscope
Not Applicable
Recruiting
- Conditions
- Urolithiasis, Calcium OxalateKidney Stone
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Target Recruit Count
- 20
- Registration Number
- NCT07071948
- Locations
- 🇨🇳
2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Phase I/II Clinical Study of SHR-1501 Combined With Adbelizumab in Patients With Malignant Tumors
Not Applicable
Not yet recruiting
- Conditions
- Patients With Advanced or Metastatic Malignant Tumors
- Interventions
- Drug: SHR-1501, Adebrelimab
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Target Recruit Count
- 203
- Registration Number
- NCT07073534
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China